Vascular endothelial growth factor: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "|first=" to " | first = ") |
Notjusttired (talk | contribs) m (Text replacement - "|first4=" to " | first4 = ") |
||
| Line 5: | Line 5: | ||
== ME/CFS == | == ME/CFS == | ||
Landi et al. (2016) found lower levels of VEGF, IL-7 and IL-16 in 100 long-term ME/CFS patients compared to controls but studies by Horning et al. (2015) and Montoya et al. (2017) did not find this statistically significant.<ref name="Abdolamir">{{Cite journal|last=Landi | first = Abdolamir | author-link=Abdolamir Landi | last2 = Broadhurst | first2=David | author-link2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell|first4= D. Lorne J. | authorlink4 = | last5 = Houghton | first5=Michael | author-link5=Michael Houghton | date = Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://pubmed.ncbi.nlm.nih.gov/26615570/?dopt=Abstract|journal=Cytokine|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|issn=1096-0023|pmc=|pmid=26615570|access-date=|quote=|via=}}</ref><ref>{{Cite journal|last=Giloteaux | first = Ludovic | author-link=Ludovic Giloteaux | last2 = O'Neal | first2 = Adam | author-link2 = | last3 = Castro-Marrero| first3 = Jesús | author-link3=Jesús Castro-Marrero | last4 = Levine|first4=Susan M. | authorlink4 = Susan Levine | last5 = Hanson | first5=Maureen R. | authorlink5 = Maureen Hanson | date = 2020-10-12|title=Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study|url=https://doi.org/10.1186/s12967-020-02560-0|journal=Journal of Translational Medicine|volume=18|issue=1|pages=387|doi=10.1186/s12967-020-02560-0|issn=1479-5876|pmc=|pmid=|access-date=|quote=|via=}}</ref> | Landi et al. (2016) found lower levels of VEGF, IL-7 and IL-16 in 100 long-term ME/CFS patients compared to controls but studies by Horning et al. (2015) and Montoya et al. (2017) did not find this statistically significant.<ref name="Abdolamir">{{Cite journal|last=Landi | first = Abdolamir | author-link=Abdolamir Landi | last2 = Broadhurst | first2=David | author-link2 = | last3 = Vernon | first3=Suzanne D. | authorlink3 = Suzanne Vernon | last4 = Tyrrell | first4 = D. Lorne J. | authorlink4 = | last5 = Houghton | first5=Michael | author-link5=Michael Houghton | date = Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://pubmed.ncbi.nlm.nih.gov/26615570/?dopt=Abstract|journal=Cytokine|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|issn=1096-0023|pmc=|pmid=26615570|access-date=|quote=|via=}}</ref><ref>{{Cite journal|last=Giloteaux | first = Ludovic | author-link=Ludovic Giloteaux | last2 = O'Neal | first2 = Adam | author-link2 = | last3 = Castro-Marrero| first3 = Jesús | author-link3=Jesús Castro-Marrero | last4 = Levine | first4 = Susan M. | authorlink4 = Susan Levine | last5 = Hanson | first5=Maureen R. | authorlink5 = Maureen Hanson | date = 2020-10-12|title=Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study|url=https://doi.org/10.1186/s12967-020-02560-0|journal=Journal of Translational Medicine|volume=18|issue=1|pages=387|doi=10.1186/s12967-020-02560-0|issn=1479-5876|pmc=|pmid=|access-date=|quote=|via=}}</ref> | ||
== Notable studies == | == Notable studies == | ||
Revision as of 01:27, December 1, 2022
 | This article is a stub. |
Vascular Endothelial Growth Factor (VEGF) or Vascular Endothelial Growth Factor A (VEGF-A) is a signal protein produced by cells that stimulates blood vessel formation (vasculogenesis and angiogenesis).[1] Vascular Endothelial Growth Factor was originally known as vascular permeability factor (VPF).
The VEGF family help maintain blood vessel and lymphatic systems.[1]
ME/CFS[edit | edit source]
Landi et al. (2016) found lower levels of VEGF, IL-7 and IL-16 in 100 long-term ME/CFS patients compared to controls but studies by Horning et al. (2015) and Montoya et al. (2017) did not find this statistically significant.[2][3]
Notable studies[edit | edit source]
- 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 Maniscalco, W. M.; D’Angio, C.T. (January 1, 2006). Laurent, Geoffrey J.; Shapiro (eds.). VASCULAR ENDOTHELIAL GROWTH FACTOR. Oxford: Academic Press. pp. 413–418. ISBN 978-0-12-370879-3. Unknown parameter
|editor2- first=ignored (help) - ↑ Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (February 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018. ISSN 1096-0023. PMID 26615570.
- ↑ Giloteaux, Ludovic; O'Neal, Adam; Castro-Marrero, Jesús; Levine, Susan M.; Hanson, Maureen R. (October 12, 2020). "Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study". Journal of Translational Medicine. 18 (1): 387. doi:10.1186/s12967-020-02560-0. ISSN 1479-5876.
